ovarian cancer screening

Register to receive a free U.S. Diagnostic Ultrasound Imaging Equipment Market report synopsis and brochure

According to a recent study published in the Journal of Clinical Oncology, researchers at the University of London (ULC) led a new test for ovarian cancer that has shown to double the detection rates of the disease compared to tradition methods. This new screening process indicates changes in the levels of CA125, a protein found in women’s blood linked to ovarian cancer.

UCL’s Professor Usha Menon said that the new procedure could change the way doctor’s screen for ovarian cancer in the UK. “There is currently no national screening programme for ovarian cancer, as research to date has been unable to provide enough evidence that any one method would improve early detection of tumours,” Professor Menon said.

Results from the trial showed that the new test can detect roughly 86% of ovarian cancer cases compared to the traditional method using a fixed level for CA125 which can identify only 48% of cancer occurrence.

“A blood test to find women at risk of ovarian cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save lives,” said Dr. James Brenton, an ovarian cancer expert at Cancer Research UK. “By tracking how the levels of the CA125 protein change over time we might have an early signal to detect tumors. Ovarian cancer is particularly hard to spot at an early stage so it’s vital that we find ways to diagnose the cancer sooner.”

However, despite how promising these results are, more studies remain to be done to test the algorithm on a larger scale to further determine its effectiveness as a screening method. Ovarian cancer has low survival rates because symptoms often do not occur until the disease has progressed to the later stages, when it is much harder to treat.

For Further Information
More on the ultrasound market in the U.S. can be found in the report published by iData entitled U.S. Market for Ultrasound Imaging Equipment. This report also covers the U.S. market segments for cardiology ultrasound equipment, radiology ultrasound equipment, obstetrics and gynecology ultrasound equipment, breast ultrasound equipment, urology ultrasound equipment, surgery ultrasound equipment, and ophthalmic ultrasound equipment.

This iData report includes ultrasound procedures by field, by specialty, and by State, using both government and private payer scheme data. Trend analysis is provided for the last 4 years.

Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about U.S. ultrasound market data or procedure data, register online or email us at [email protected] for a U.S. Market for Ultrasound Imaging Equipment report brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by country, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.


Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected]taresearch.net with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook: facebook.com/iDataResearch
Follow us on LinkedIn: linkedin.com/company/idata-research
Follow us on Twitter: twitter.com/iDataResearch